Results 81 to 90 of about 389,087 (235)

Health and Survival Impacts of Early Childhood Development Programmes: The Case of the Happy Child Programme in Brazil

Review of Development Economics, EarlyView.
ABSTRACT This paper adds to the growing evidence on the impacts of early childhood development (ECD) programming by examining one of the world's largest home visitation programmes, the Happy Child Programme in Brazil, and its impacts on child vaccination and preventable death rates.
Raquel Tebaldi, Franziska Gassmann, Bruno Martorano   +2 more
wiley   +1 more source

Duration of Immunity against Mycobacterium bovis following Neonatal Vaccination with Bacillus Calmette-Guerin Danish: Significant Protection against Infection at 12, but Not 24, Months [PDF]

, 2012
Vaccination of neonatal calves with Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces a significant degree of protection against bovine tuberculosis, caused by infection with virulent M. bovis.
McAulay, M., Hewinson, R. G., Thom, M. L., Villarreal-Ramos, B., Vordermeier, H. M., Clifford, D., Hope, J. C.; id_orcid   +6 more
core   +1 more source

The whole genome sequence of Polish vaccine strain Mycobacterium bovis BCG Moreau

Microbiology Spectrum
Currently, tuberculosis immunoprophylaxis is based solely on Bacillus Calmette-Guérin (BCG) vaccination, and some of the new potential tuberculosis vaccines are based on the BCG genome. Therefore, it is reasonable to analyze the genomes of individual BCG
Katarzyna Krysztopa-Grzybowska, Jakub Lach, Maciej Polak, Dominik Strapagiel, Jaroslaw Dziadek, Marcin Olszewski, Aleksandra A. Zasada, Aniela Darlińska, Anna Lutyńska, Ewa Augustynowicz-Kopeć   +9 more
doaj   +1 more source

Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur

BMC Microbiology, 2011
Background Bacille Calmette-Guerin (BCG) is currently the only available vaccine against tuberculosis (TB) and comprises a heterogeneous family of sub-strains with genotypic and phenotypic differences. The World Health Organization (WHO) affirms that the
Degrave Wim M, Castello-Branco Luiz RR, da Silva Renata F, Pereira Melissa P, Gomes Leonardo HF, Correa Paloma R, Kalume Dario E, Berrêdo-Pinho Marcia, Mendonça-Lima Leila   +8 more
doaj   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis

, 2020
Tuberculosis still claims more lives than any other pathogen, and a vaccine better than BCG is urgently needed. One of the challenges for novel TB vaccines is to protect against all Mycobacterium tuberculosis lineages, including the most virulent ones ...
권기웅, 신성재
core   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

BJU International, Volume 138, Issue 4, Page 607-619, October 2026.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan, Ethan Senior, Jessica Kendall, Jamie B. Oughton, Fiona Collinson, Jon Griffin, Rachel Hubbard, Steven Kennish, Aidan Noon, Derek J. Rosario, Irbaz B. Riaz, Julie Telliez, James W. F. Catto, Syed A. Hussain   +13 more
wiley   +1 more source

Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. [PDF]

, 2009
Bacille Calmette-Guérin (BCG) vaccination induces a marked increase in the interferon (IFN)-gamma response to Mycobacterium tuberculosis purified protein derivative (Mtb PPD) in UK adolescents, but not in Malawian adolescents.
Gorak-Stolinska, P., Crampin, A.C., Fine, Paul E.M., Paul E M Fine (16181840), Newport, Melanie J, Mvula, Hazzie, Ben-Smith, A., Weir, Rosemary E., Hazzie Mvula (271278), Fine, P.E., Nuala McGrath (230042), Crampin, Amelia C, Keith Branson (239422), Mvula, H., Hazel M Dockrell (10414616), Patricia Gorak-Stolinska (356875), McGrath, Nuala, Blitz, R., Gorak-Stolinska, Patricia, Branson, K., Ben‐Smith, Anne, Fine, Paul EM, Amelia C Crampin (10281422), Crampin, Amelia C., Ben-Smith, Anne, Weir, R.E., McGrath, N., Dockrell, Hazel M., Floyd, Sian, Rose Blitz (356877), Newport, M.J., Gorak‐Stolinska, Patricia, Anne Ben-Smith (244056), Blitz, Rose, Melanie Newport (4461202), Lalor, Maeve K., Lalor, M.K., Maeve K Lalor (16181825), Dockrell, H.M., Rosemary E Weir (16181828), Sian Floyd (239400), Weir, Rosemary E, Lalor, Maeve K, Dockrell, Hazel M, Newport, Melanie J., Branson, Keith   +45 more
core   +1 more source

BCG Vaccination and Tuberculosis in Japan.

Journal of Epidemiology, 2003
This paper summarizes Bacillus Calmette-Guerin (BCG) vaccination and revaccination policies in Japan, its cost-effectiveness, side effects, proposed selective vaccination strategy, and present tuberculosis situation in Japanese perspectives based on Medline database and other published reports.
Rahman, Mahbubur, Takahashi, Osamu, Goto, Masashi, Fukui, Tsuguya   +3 more
openaire   +3 more sources

Past and Present Vaccinations in Sweden

Acta Paediatrica, EarlyView.
Sven Arne Silfverdal
wiley   +1 more source